Immune recovery during HIV infection is profoundly influenced by inflammation, with chronic inflammation being consistently associated to disease progression and poor prognosis. In addition, numerous studies have shown that antiretroviral therapy (ART) does not resolve inflammation. Therefore, understanding the drivers of chronic inflammation is of considerable interest. This presentation will review current knowledge on the factors known to influence inflammation during ART; such as the HIV reservoir, microbial translocation and co-infections with other viruses. Recent studies on the microbiome will be presented in an effort to clarify whether changes in the microbiome are a cause or consequence of chronic inflammation. Moreover, we will describe how metabolic factors and health risk behaviors also contribute to chronic inflammation in persons living with HIV. Finally, the use of multi-omics approaches and state-of-the-art methodologies will be highlighted as means to unravel the mechanisms underlying chronic inflammation in HIV infection and, ultimately, to identify optimal therapeutic targets.